Amyloid-β immunotherapy for Alzheimer's disease: the end of the beginning

D Schenk - Nature Reviews Neuroscience, 2002 - nature.com
The agents that are available at present for the management of Alzheimer's disease treat
only the symptoms of neurodegeneration and, at best, result in modest, short-term …

[引用][C] Amyloid-β immunotherapy for Alzheimer's disease. The end of the beginning

D SCHENK - Nat. Rev. Neurosci., 2003 - cir.nii.ac.jp

Amyloid-[beta] immunotherapy for Alzheimer's disease: the end of the beginning

D Schenk - Nature Reviews Neuroscience, 2002 - go.gale.com
The agents that are available at present for the management of Alzheimer's disease treat
only the symptoms of neurodegeneration and, at best, result in modest, short-term …

Opinion: Amyloid-β immunotherapy for Alzheimer's disease: the end of the beginning.

D Schenk - Nature Reviews Neuroscience, 2002 - search.ebscohost.com
The agents that are available at present for the management of Alzheimer's disease treat
only the symptoms of neurodegeneration and, at best, result in modest, short-term …

[PDF][PDF] Amyloid-β immunotherapy for Alzheimer's disease: the end of the beginning

D Schenk - New York Times, 2002 - researchgate.net
The agents that are available at present for the management of Alzheimer's disease treat
only the symptoms of neurodegeneration and, at best, result in modest, short-term …

[引用][C] Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning.

D Schenk - Nature reviews. Neuroscience, 2002 - europepmc.org
Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning. - Abstract -
Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …

[引用][C] Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning

D Schenk - Nature reviews. Neuroscience, 2002 - pubmed.ncbi.nlm.nih.gov
Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning Amyloid-beta
immunotherapy for Alzheimer's disease: the end of the beginning Nat Rev Neurosci. 2002 …

[引用][C] Amyloid-β immunotherapy for Alzheimer's disease: the end of the beginning

D Schenk - Nature Reviews Neuroscience, 2002 - cir.nii.ac.jp
Amyloid-β immunotherapy for Alzheimer's disease: the end of the beginning | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文 …

[引用][C] Opinion: Amyloid-[beta] immunotherapy for Alzheimer's disease: the end of the beginning

D Schenk - Nature Reviews. Neuroscience, 2002 - Nature Publishing Group

[引用][C] Amyloid-β immunotherapy for Alzheimer's disease: the end of the beginning

D SCHENK - Nature reviews. Neuroscience, 2002 - Nature Publishing Group